Avanthiga Subrhamanian
Papers
1
Total Citations
1
H-Index
1
About
Avanthiga Subrhamanian is a clinical researcher whose work bridges nuclear medicine and musculoskeletal pain management. Her primary research areas include molecular imaging, particularly the use of [18F]NaF PET/CT for diagnosing and guiding treatment of axial joint arthropathies. Her most notable contribution is the single-arm phase 2 trial on the efficacy and safety of [18F]NaF PET/CT guided intraarticular blocks for lumbar facet joint and sacroiliac joint arthropathy. This study, published in 2025, represents a pioneering effort to combine advanced PET imaging with targeted therapeutic interventions, potentially improving diagnostic accuracy and treatment outcomes for patients with chronic lower back pain. While her citation count is currently modest—with her landmark paper garnering 1 citation—the work is early-stage and holds significant promise for reshaping clinical protocols in pain management. Subrhamanian’s research is particularly impactful for its methodological innovation, offering a non-invasive, image-guided alternative to traditional diagnostic blocks. Her achievements underscore a commitment to precision medicine, and her work is poised to influence future guidelines in interventional pain management and nuclear medicine.
Research Focus
Key Achievements
Top Papers
- 1